Chi-Chen Lin was born in China on October 1st, 1977. From 2000 to 2007, Lin attended the Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng-Kung University, Taiwan, where he received the B.S. and Ph.D. degrees. His research interests concentrated on DNA vaccine development. He directed his efforts towards designing the most effective therapeutic HER-2/neu and EGFR DNA vaccine for the treatment of endogenous overexpressing HER-2/neu or EGFR-associated malignancies. From 2006 to 2007, Lin did postdoctoral training. In 2008, he joined the Institute of Biomedicine at the National Chung-Hsing University, Taiwan, as an Assistant Professor. Recently, Lin's major research interests focus on designing therapeutic vaccines that target other cancers with defined tumor antigens by the principle and strategies that we used for EGFR and HER-2/neu vaccine development, seeking a novel adjuvant for dendritic cells (DCs) activation, and developing innovative noninvasive method to delivery DNA vaccine. His study aims at eliciting a better understanding of the underlying mechanisms of the therapeutic DNA vaccine which we designed and provide valuable information to vaccine designation in the future.
Biography Updated on 12 January 2011